Chief Financial Officer
Ramzi Benamar joined BELLUS Health in December 2020 as Chief Financial Officer.
Mr. Benamar has over 20 years of financial, strategic planning and business operations experience in the biopharmaceutical sector.
Prior to Bellus Health, he served as Chief Financial Officer of DBV Technologies where he was instrumental in managing the balance sheet and leading the capital deployment strategy. Prior to joining DBV Technologies, Mr. Benamar was the VP of finance and Head of financial planning and analysis at Spark Therapeutics until the acquisition of the company by Roche Holding. Mr. Benamar provided financial leadership across the entire company, strengthen the finance organization and was a key contributor to the transition to a commercial stage organization. Mr. Benamar also held key finance and business operations roles of increasing responsibilities at Shire (acquired by Takeda) Johnson and Johnson, Purdue Pharma and Merck.
Mr. Benamar holds a Master of Business Administration and Bachelor of Business Administration from Temple University, as well as a Master from the University of Sciences in Philadelphia.